With the fall launch of its updated Covid-19 vaccine likely weeks away, Moderna Inc. is forecasting sales of $6 to $8 billion, up from the $5 billion it previously forecast. But there's one major unknown for the Cambridge biotech.
With the fall launch of its updated Covid-19 vaccine likely weeks away, Moderna Inc. is forecasting sales of $6 to $8 billion, up from the $5 billion it previously forecast. But there's one major unknown for the Cambridge biotech.
